Novartis AG's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Assets" stands at 13.91 percent as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Return On Assets" stands at 13.91 Percent. This represents an increase of 0.59 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.90 percentage points compared to the value the year prior.
The 1 year change in percentage points is -3.90.
The 3 year change in percentage points is -3.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Return On Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Return On Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Assets | 280,205,508,085.11 |